New Alliance with Ohio State focuses on medical innovation
Cleveland Clinic Innovations and The Ohio State University’s Technology Commercialization and Knowledge Transfer Office have entered into an alliance to accelerate and commercialize medical innovations.
This collaborative effort, which creates the largest medical commercialization network in Ohio, is focused on improving and extending the lives of patients, and will have a positive impact on the state of Ohio through job creation and economic development.
Cleveland Clinic and Ohio State will work together to develop new medical innovations created by researchers, physicians, faculty and administrative staff at both institutions. These innovations come in many forms, such as medical devices, patient services, new medical software systems, consumer products and startup companies.
Juventas Therapeutics Raises $22.2 Million Series B Financing
Juventas Therapeutics, a clinical-stage regenerative medicine company, announced today that it has closed a $22.2 million Series B financing that was co-led by Triathlon Medical Venture Partners and New Science Ventures. All previous venture firms, including Fletcher Spaght Ventures, Reservoir Venture Partners and Early Stage Partners participated in the round. Also joining the syndicate are new investors Takeda Ventures, Venture Investors, Global Cardiovascular Innovation Center, Tri-State Growth Fund, Glengary and select angel investors.
Notre Dame to collaborate with Cleveland Clinic
The University of Notre Dame and the Cleveland Clinic announced a partnership Thursday to develop and market medical technology and innovations, marking the school's latest step to strengthen its reputation as a research institution.
Notre Dame research vice president Robert Bernhard said the collaboration with the well-known academic hospital will help move ideas and technology from the school to the marketplace faster, thanks to the clinic's commercialization arm. The partnership also will help the school make better decisions about what technology to market, he said.